TY - JOUR
T1 - Free Needles for Intravenous Drug Users at Risk for AIDS
T2 - Current Developments in New York City
AU - Des Jarlais, Don C.
AU - Hopkins, William
PY - 1985/12/5
Y1 - 1985/12/5
N2 - To the Editor: In the absence of either effective treatment or effective vaccines, reducing transmission-related behavior is the most practical means of trying to control the acquired immunodeficiency syndrome (AIDS) epidemic. Intravenous drug users constitute the second largest group of persons with AIDS in the United States; 2249 of the 13,216 U.S. cases have intravenous drug use as their primary risk factor, and an additional 1144 have both intravenous drug use and male homosexuality as risk factors. Furthermore, in the United States, intravenous drug users are the primary source of transmission to heterosexuals and to children (AIDS Activity, Centers for.
AB - To the Editor: In the absence of either effective treatment or effective vaccines, reducing transmission-related behavior is the most practical means of trying to control the acquired immunodeficiency syndrome (AIDS) epidemic. Intravenous drug users constitute the second largest group of persons with AIDS in the United States; 2249 of the 13,216 U.S. cases have intravenous drug use as their primary risk factor, and an additional 1144 have both intravenous drug use and male homosexuality as risk factors. Furthermore, in the United States, intravenous drug users are the primary source of transmission to heterosexuals and to children (AIDS Activity, Centers for.
UR - http://www.scopus.com/inward/record.url?scp=0022365332&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0022365332&partnerID=8YFLogxK
U2 - 10.1056/NEJM198512053132311
DO - 10.1056/NEJM198512053132311
M3 - Letter
C2 - 4058552
AN - SCOPUS:0022365332
SN - 0028-4793
VL - 313
SP - 1476
JO - New England Journal of Medicine
JF - New England Journal of Medicine
IS - 23
ER -